Uniogen

Uniogen is a Finnish biotechnology company headquartered in Turku that develops and manufactures diagnostic tests, assay components and laboratory instruments, and also provides contract development and manufacturing (CDMO) and OEM services to the in-vitro diagnostics (IVD) and life-science industries. The company was formed when three Turku-based biotechnology businesses — Kaivogen (cancer diagnostics, immunoassays and antibody testing), Labrox (high-end laboratory instruments and diagnostic readers) and Abacus Diagnostica (rapid PCR and molecular testing) — announced their merger in September 2021 and combined into Uniogen Oy at the beginning of 2022. Uniogen describes itself as a frontrunner in diagnostics solutions and instrumentation for life sciences, with expertise spanning early cancer detection, immunoassays and assay components, and advanced instrumentation. Uniogen's product and service portfolio includes coated microplates and custom coated microplates, laboratory buffers, Upcon® upconverting nanoparticle (UCNP) technology, single-mode microplate readers, and fully assembled assay kits. Its CDMO and OEM offering covers custom manufacturing of microtiter plates, buffers, reagents and assay kits, assay development and R&D services, and instrument solutions, with products available to be manufactured under ISO13485 certification upon request. The company states it has 20 years of experience in assay development and the diagnostics market, hundreds of customers over the years, and a Net Promoter Score of 80 from its latest customer satisfaction survey. On the diagnostics side, Uniogen is pursuing earlier cancer detection, with ovarian cancer as its first target through a glycovariant immunoassay, the GLYVAR Ovarian (RUO) assay. The company positions itself as a partner for diagnostic and life-science companies worldwide, helping partners bring new products to market through tailored development and manufacturing services. Uniogen is headquartered in Turku, Finland, and employs around 75 life-science professionals according to its own about page, while Finnish Wikipedia reports nearly 100 employees. In 2022, roughly 80 percent of Uniogen's sales came from international markets and its products were sold in about 100 countries. The combined revenue of the companies that formed Uniogen was 15 million euros in 2021. Uniogen products are sold globally through partner channels.

Uniogen Oy is a Turku-based biotechnology company founded in 2021 through the merger of three Turku biotechnology businesses: Abacus Diagnostica, Labrox and Kaivogen. The three companies announced their merger in September 2021 and combined into Uniogen Oy at the beginning of 2022. Each brought a distinct capability: Kaivogen specialized in cancer diagnostics, immunoassays and antibody testing; Labrox was an innovator of high-end laboratory instruments and diagnostic readers; and Abacus Diagnostica was a frontrunner in rapid PCR and molecular testing. As Uniogen describes it, the merger combined immunoassay, PCR and instrumentation expertise into a single company. The combined revenue of the companies that formed Uniogen was 15 million euros in 2021. In 2022, roughly 80 percent of Uniogen's sales came from international markets, and its products were sold in about 100 countries. The company is headquartered in Turku, Finland; its own about page states it employs around 75 life-science professionals, while Finnish Wikipedia reports nearly 100 employees. Uniogen built its business around two connected pillars. The first is diagnostics, with a focus on earlier cancer detection; its first target is ovarian cancer, pursued through a glycovariant immunoassay marketed as the GLYVAR Ovarian (RUO) assay. The second is as a CDMO and OEM partner for the IVD and life-science industries, providing assay development and R&D services, contract manufacturing of microplates, buffers, reagents and fully assembled assay kits, and instrument solutions including customizable microplate readers. The company states it has 20 years of experience in assay development and the diagnostics market, has served hundreds of customers over the years, and recorded a Net Promoter Score of 80 in its latest customer satisfaction survey. Its products include coated microplates, custom coated microplates, laboratory buffers, Upcon® upconverting nanoparticles and single-mode microplate readers, with components and custom products available to be manufactured under ISO13485 certification upon request. Uniogen products are sold globally through partner channels. The company continues to promote its Upcon® upconverting nanoparticle technology and to participate in biotechnology events, and in 2026 it announced the appointment of Christine Richter, PhD, MBA, to its board of directors.

• Abacus Diagnostica, Labrox and Kaivogen announce their merger.

• Uniogen Oy is founded; the combined revenue of the merging companies is 15 million euros.

• The three companies combine into Uniogen Oy at the beginning of the year.

• About 80 percent of Uniogen's sales come from international markets; products are sold in about 100 countries.

• Uniogen announces the appointment of Christine Richter, PhD, MBA, to its board of directors.

A Finnish life-science and biotech partner combining immunoassay, PCR and instrumentation expertise, positioned around earlier cancer detection and trusted CDMO/OEM services for the IVD and life-science industries.

• GLYVAR Ovarian (RUO) assay

  Glycovariant immunoassay aiming for earlier ovarian cancer detection; Uniogen's first cancer target.

• Upcon® upconverting nanoparticle technology

  A complete solution for low-background measurement in various applications.

• Coated microplates and custom coated microplates

  Catalogue and customized microplates, including streptavidin-coated plates used in time-resolved fluorescence immunoassays.

• Laboratory buffers

  Catalogue and custom laboratory buffers tailored to assay needs.

• Microplate readers

  Low-maintenance single-mode microplate readers with customizable features.

• CDMO and OEM services

  Contract manufacturing of microtiter plates, buffers, reagents and fully assembled assay kits, plus assay development and instrument solutions.

1. 1Uniogen | Early Cancer Detection & Diagnostic CDMO Solutionsuniogen.com
2. 2CDMO & OEM Services for Biotech & Life Sciences | Uniogenuniogen.com
3. 3Assay Components, Microplates & Buffers | Uniogenuniogen.com
4. 4About Uniogen | Diagnostics Solutions & Instrumentationuniogen.com
5. 5Uniogenwikidata.org
6. 6Uniogenfi.wikipedia.org